Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

The at-home test is able to analyze a man's sperm count in less than 30 minutes with 97% accuracy, Sonora Quest said.

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...

Guggenheim analyst Subbu Nambi noted that Grail (GRAL) announced a partnership yesterday with Quest Diagnostics (DGX) to offer Galleri, ...

Jan 30 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by a robust appetite for its ...

Grail (GRAL) is rallying 15% and set a new all-time high after Quest Diagnostics (DGX) and GRAL announced earlier today that ...

The company, co-founded by Cleveland Clinic in 2013, had a couple major objectives for the funding: expanding the commercial ...

Quest Diagnostics Inc. hit a new 52-week high, surpassing its previous peak of $168.17, which the company achieved on February 11th.

Quest said that while it will continue to look at acquisition opportunities, it plans to focus on integrating and driving productivity of recently purchased assets.